Ultrasonic Package for Buchi Mini Spray Dryer S-300
Closed Pre-Solicitation Posted
- Solicitation number
- CDER-2026-133241
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Place of performance
- Silver Spring, Maryland 20993, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The FDA's Center for Drug Evaluation and Research (CDER) is conducting market research to identify sources for an Ultrasonic Package for Buchi Mini Spray Dryer S-300, with responses due by July 20, 2026. No set-aside is anticipated. The ultrasonic nozzle must integrate seamlessly into FDA-owned Buchi Mini Spray Dryer S-300 and B-290 equipment and produce spray-dried powders with particles up to 60 microns for intranasal drug delivery applications, with adjustable ultrasonic power. Delivery and installation must occur within 45 calendar days of award at the FDA facility in Silver Spring, Maryland. The contractor must provide Factory Acceptance Test documentation, validation, training for six scientists, and one-year original equipment manufacturer warranty. Performance runs approximately September 1, 2026 through August 31, 2027 on a firm fixed-price basis with Net-30 payment terms. All costs—packaging, shipping, delivery, installation, and maintenance—must be included in pricing. Responses should include company overview, detailed product specifications demonstrating capability against technical requirements, GSA Schedule contract information if applicable, Section 508 accessibility conformance details, and informational pricing. Submit via email to david.kramer@fda.hhs.gov by July 20, 2026 at 1:00 p.m. Central Time, referencing CDER-2026-133241. NAICS 334516 applies, with small business size standard of 1,000 employees; businesses of any size may respond. This announcement does not obligate award and responses will not be considered adequate for a future solicitation.
Notice text
The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) requires an Ultrasonic Package for Buchi Mini Spray Dryer S-300. Advanced pharmaceutical manufacturing is an innovative pharmaceutical manufacturing technology, which has the potential to enhance drug quality, improve the reliability and robustness of the manufacturing process and supply chain, and increase timely access to quality medicines for the American public. One of FDA’s research priorities is to explore advanced manufacturing techniques, including manufacturing of spray dried powder for intranasal drug delivery.
CDER requires an Ultrasonic Package for Buchi Mini Spray Dryer S-300 that can be installed on Buchi mini spray dryer S-300 and B-290. The ultrasonic nozzle should be capable of producing spray dried powders with ideal particle size for intranasal drug delivery (to produce particles up to sixty (60) microns).
Files
| File | Type | Posted |
|---|---|---|
| CDER-2026-133241 Buchi Ultrasonic Package for Mini Spray Dryer S-300.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity